CG
MRNA icon

Cutler Group’s Moderna MRNA Stock Holding History

Cutler Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$13K Buy
130
+80
+160% +$8.06K ﹤0.01% 1186
2023
Q4 		$4K Sell
50
-4,992
-99% -$420K ﹤0.01% 2848
2023
Q3 		$520K Sell
5,042
-3,182
-39% -$355K 0.05% 411
2023
Q2 		$999K Sell
8,224
-3,351
-29% -$447K 0.14% 173
2023
Q1 		$1.78M Sell
11,575
-38,121
-77% -$6.29M 0.18% 110
2022
Q4 		$8.93M Buy
49,696
+38,531
+345% +$6.3M 0.75% 14
2022
Q3 		$1.32M Sell
11,165
-34,793
-76% -$5.28M 0.09% 227
2022
Q2 		$6.57M Sell
45,958
-20,882
-31% -$2.98M 0.46% 28
2022
Q1 		$11.5M Buy
66,840
+64,550
+2,819% +$10.9M 0.61% 14
2021
Q4 		$581K Buy
+2,290
New +$670K 0.02% 667
2021
Q3 		– Sell
-700
Closed -$258K – 6121
2021
Q2 		$164K Sell
700
-1,327
-65% -$237K 0.01% 1483
2021
Q1 		$265K Buy
2,027
+747
+58% +$108K 0.01% 1086
2020
Q4 		$133K Buy
1,280
+1,000
+357% +$101K 0.01% 1336
2020
Q3 		$19K Sell
280
-3,580
-93% -$250K ﹤0.01% 2499
2020
Q2 		$247K Sell
3,860
-2,364
-38% -$129K 0.02% 752
2020
Q1 		$186K Buy
6,224
+3,224
+107% +$74.2K 0.01% 991
2019
Q4 		$58K Sell
3,000
-1,360
-31% -$24.1K ﹤0.01% 1533
2019
Q3 		$69K Buy
4,360
+2,360
+118% +$34.9K 0.01% 1312
2019
Q2 		$29K Buy
+2,000
New +$43K ﹤0.01% 1933
2019
Q1 		– Sell
-100
Closed -$1K – 4491
2018
Q4 		$1K Buy
+100
New +$1.64K ﹤0.01% 3655

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cutler Group's MRNA Position: Q1 2024 in Review

Cutler Group increased its Moderna (MRNA) stake by 160% in Q1 2024, buying an estimated $8.06K and bringing the position to 130 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #1186.

Cutler Group first reported a position in MRNA in Q4 2018 and has held it in 20 quarters since. The position peaked at $11.5M in Q1 2022. 902 funds tracked by Wall St. Rank hold MRNA as of Q1 2024.

  • Cutler Group held 130 shares of Moderna worth $13K as of Q1 2024.
  • Cutler Group bought 80 Moderna shares in Q1 2024, an estimated $8.06K.
  • Moderna made up ﹤0.01% of Cutler Group's portfolio in Q1 2024, its #1186 holding.
  • Cutler Group first reported a position in Moderna in Q4 2018 and has held it in 20 quarters since.
  • Cutler Group's Moderna position peaked at $11.5M in Q1 2022.
  • 902 funds tracked by Wall St. Rank held Moderna as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.